Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
17β-Estradiol is the major pre-menopausal bioactive estrogen and an active metabolite of testosterone.1,2,3 It is produced primarily by the ovary, and to a lesser extent, by the adrenals, testes, and adipose tissue, as well as by the placenta during pregnancy.1 17β-Estradiol binds to estrogen receptors localized to the nucleus, cytoplasm, and plasma membrane and induces gene transcription or non-genomic intracellular signaling in a location-dependent manner.2 It regulates reproductive development in females and spermatogenesis in males, as well as various non-reproductive processes including lipid and glucose homeostasis, bone mass maintenance, cognition, energy balance, and dilation of blood vessels.2,3 17β-Estradiol deficiency due to hypogonadism or 17α-hydroxylase/17,20-lyase deficiency is associated with fatigue, incontinence, osteoporosis, depression, emotional instability, and hot flashes. Formulations containing 17β-estradiol have been used in the treatment of menopause symptoms and the prevention of osteoporosis.
WARNING This product is not for human or veterinary use.
1. Estrogen as a key regulator of energy homeostasis and metabolic health. Biomed. Pharmacother. 156, 113808 (2022).
2. Estradiol: A steroid with multiple facets. Horm. Metab. Res. 50(5), 359-374 (2018).
3. The impact of estradiol on neurogenesis and cognitive functions in Alzheimer’s disease. Cell Mol. Neurobiol. 40(3), 283-299 (2019).
The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-